Cargando…
Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema
SIMPLE SUMMARY: Indocyanine green lymphangiography (ICG-L) allows real-time investigation of lymphatics; however, the applicability in evaluating breast cancer-related lymphedema (BCRL) is sparse and not well established. In this prospective study, we aimed to validate ICG-L assessment of BCRL in a...
Autores principales: | Jørgensen, Mads Gustaf, Toyserkani, Navid Mohamadpour, Hansen, Frederik Christopher Gulmark, Thomsen, Jørn Bo, Sørensen, Jens Ahm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063087/ https://www.ncbi.nlm.nih.gov/pubmed/33810570 http://dx.doi.org/10.3390/cancers13071540 |
Ejemplares similares
-
Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial
por: Gulmark Hansen, Frederik C., et al.
Publicado: (2023) -
Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2020) -
Adipose‐derived regenerative cells and lipotransfer in alleviating breast cancer‐related lymphedema: An open‐label phase I trial with 4 years of follow‐up
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Correction to: Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2018)